AIC
SUPN icon

Ameritas Investment Company’s Supernus Pharmaceuticals SUPN Stock Holding History

Ameritas Investment Company’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-63
Closed -$1.65K – 1916
2021
Q1 		$1.65K Buy
+63
New +$1.76K ﹤0.01% 1970

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Ameritas Investment Company's SUPN Position: Q2 2021 in Review

Ameritas Investment Company sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 63 shares — an estimated $1.65K sold.

Ameritas Investment Company first reported a position in SUPN in Q1 2021 and held it in 1 quarter. The position peaked at $1.65K in Q1 2021. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Ameritas Investment Company reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 63 Supernus Pharmaceuticals shares in Q2 2021, an estimated $1.65K.
  • Ameritas Investment Company first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Ameritas Investment Company's Supernus Pharmaceuticals position peaked at $1.65K in Q1 2021.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.